MiMedx Group, Inc. Inventory Write-down
MiMedx Group, Inc. (MDXG) reported Inventory Write-down of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2023-02-28
- MiMedx Group, Inc. inventory write-down for the quarter ending 2022-12-31 was $0.00.
- MiMedx Group, Inc. inventory write-down for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- MiMedx Group, Inc. inventory write-down for the quarter ending 2021-12-31 was $0.00.
- MiMedx Group, Inc. inventory write-down for the quarter ending 2021-09-30 was $500.00K, a 986.96% increase year-over-year.
- MiMedx Group, Inc. inventory write-down for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- MiMedx Group, Inc. inventory write-down for fiscal 2021 was $700.00K.
- MiMedx Group, Inc. inventory write-down for fiscal 2019 was $0.00.
- MiMedx Group, Inc. inventory write-down for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 6 month as first filed | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $500.00K derived: sum of 2 quarters · filed 2023-02-28 | $700.00K 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $500.00K 10-Q · filed 2022-11-02 | $700.00K 10-Q · filed 2022-11-02 | |||
| 2020-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$171.00K 10-Q · filed 2020-11-04 | |||
| 2020-06-30 | -$217.00K 10-Q · filed 2020-08-04 | ||||
| 2019-12-31 | -$413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-06 | -$500.00K derived: sum of 2 quarters · filed 2020-11-04 | $0.00 derived: sum of 3 quarters · filed 2020-11-04 | $0.00 10-K · filed 2020-07-06 | |
| 2019-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $413.00K derived: sum of 2 quarters · filed 2020-11-04 | $413.00K 10-Q · filed 2020-11-04 | ||
| 2019-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $500.00K 10-Q · filed 2020-08-04 | $116.00K 10-Q · filed 2020-07-06 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-07-06 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-07-06 | ||||
| 2018-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-06 | $85.00K 10-Q · filed 2020-07-06 | $85.00K derived: sum of 3 quarters · filed 2020-07-06 | $135.00K derived: sum of 4 quarters · filed 2020-07-06 | |
| 2018-03-31 | -$51.00K 10-Q · filed 2020-07-06 | -$51.00K derived: sum of 2 quarters · filed 2020-07-06 | -$1.00K derived: sum of 3 quarters · filed 2020-07-06 | $77.00K derived: sum of 4 quarters · filed 2020-07-06 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-06 | $50.00K derived: sum of 2 quarters · filed 2020-07-06 | $128.00K derived: sum of 3 quarters · filed 2020-07-06 | $203.00K 10-K · filed 2020-07-06 | |
| 2017-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $128.00K derived: sum of 2 quarters · filed 2017-10-31 | $203.00K 10-Q · filed 2017-10-31 | $217.00K derived: sum of 4 quarters · filed 2020-03-17 | |
| 2017-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $153.00K 10-Q · filed 2017-07-31 | $167.00K derived: sum of 3 quarters · filed 2020-03-17 | $414.00K derived: sum of 4 quarters · filed 2020-03-17 | |
| 2017-03-31 | $75.00K 10-Q · filed 2017-05-01 | $89.00K derived: sum of 2 quarters · filed 2020-03-17 | $336.00K derived: sum of 3 quarters · filed 2020-03-17 | $826.00K derived: sum of 4 quarters · filed 2020-03-17 | |
| 2016-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $261.00K derived: sum of 2 quarters · filed 2020-03-17 | $751.00K derived: sum of 3 quarters · filed 2020-03-17 | $1.49M 10-K · filed 2020-03-17 | |
| 2016-09-30 | $247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $737.00K derived: sum of 2 quarters · filed 2017-10-31 | $1.47M 10-Q · filed 2017-10-31 | $1.47M derived: sum of 4 quarters · filed 2017-10-31 | |
| 2016-06-30 | $490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $1.22M 10-Q · filed 2017-07-31 | $1.22M derived: sum of 3 quarters · filed 2017-07-31 | $1.22M derived: sum of 4 quarters · filed 2017-07-31 | |
| 2016-03-31 | $734.00K 10-Q · filed 2017-05-01 | $734.00K derived: sum of 2 quarters · filed 2017-05-01 | $734.00K derived: sum of 3 quarters · filed 2017-05-01 | $734.00K derived: sum of 4 quarters · filed 2017-05-01 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $0.00 10-Q · filed 2016-08-02 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |